ARCT
NASDAQ · Biotechnology
Arcturus Therapeutics Holdin
$13.02
-0.19 (-1.44%)
Open$13.42
Previous Close$13.21
Day High$13.66
Day Low$12.87
52W High$24.17
52W Low$5.50
Volume—
Avg Volume848.0K
Market Cap369.50M
P/E Ratio—
EPS$-3.31
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+102.8% upside
Current
$13.02
$13.02
Target
$26.41
$26.41
$16.23
$26.41 avg
$33.18
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.01M | 115.55M | 31.39M |
| Net Income | -68,170,177 | -83,394,263 | -5,088,256 |
| Profit Margin | -80.2% | -76.2% | -16.2% |
| EBITDA | -75,892,214 | -97,998,645 | -7,015,778 |
| Free Cash Flow | — | — | -5,929,972 |
| Rev Growth | -26.4% | -26.4% | +5.3% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |